Time course of morphine withdrawal and preproenkephalin gene expression in the periaqueductal gray of rats

Molecular Brain Research

Volumn 55, Issue 2, 1998, Pages 221-231

  Fukunaga, Yuko ^a   Nishida, Shigeru ^a   Inoue, Norihiro ^a   Miyamoto, Masahiko ^a   Kishioka, Shiroh ^a   Yamamoto, Hiroyuki ^a  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Body weight loss; Caudal periaqueductal gray; In situ hybridization; Morphine withdrawal; Plasma corticosterone elevation; Preproenkephalin mRNA; Rat

Indexed keywords

CORTICOSTERONE; MESSENGER RNA; MORPHINE; NALOXONE; PREPROENKEPHALIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DRUG WITHDRAWAL; GENE EXPRESSION; MALE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; WEIGHT REDUCTION;

ANIMALS; BODY WEIGHT; CORTICOSTERONE; ENKEPHALINS; GENE EXPRESSION REGULATION; INJECTIONS, SUBCUTANEOUS; MALE; MORPHINE; NALOXONE; PERIAQUEDUCTAL GRAY; PROTEIN PRECURSORS; RATS; RATS, SPRAGUE-DAWLEY; STRESS; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 0032052713     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(97)00374-4     Document Type: Article

References (68)

1. Al-Rodhan N., Chipkin R., Yaksh T.L. The antinociceptive effects of SCH-32615, a neutral endopeptidase (enkephalinase) inhibitor, microinjected into the periaqueductal, ventral medulla and amygdala. Brain Res. 520:1990;123-130.
2. Bandler R., Shiply M.T. Columnar organization in the midbrain periaqueductal gray: modules for emotional expression? TINS. 17:1994;379-389.
3. Basheer R., Tempel A. Morphine-induced reciprocal alterations in Gαs and opioid peptide mRNA levels in discrete brain regions. J. Neurosci. Res. 36:1993;551-557.
4. Bhargava H.N. New in vivo evidence for narcotic agonistic property of leucine-enkephalin. J. Pharm. Sci. 67:1977;136-137.
5. Bhargava H.N. Opiate-like action of methionine-enkephalin in inhibiting morphine abstinence syndrome. Eur. J. Pharmacol. 41:1977;81-84.
6. Bozarth M.A., Wise R.A. Anatomically distinct opiate receptor fields mediate reward and physical dependence. Science. 224:1984;516-517.
7. Brandao M.L. Involvement of opioid mechanisms in the dorsal periaqueductal gray in drug abuse. Rev. Neurosci. 4:1993;397-405.
8. Carrive P., Bandler R. Viscerotopic organization of neurons subserving hypotensive reactions within the midbrain periaqueductal gray: a correlative functional and anatomical study. Brain Res. 541:1991;206-215.
9. Chen Y., Mestek A., Liu J., Hurley J.A., Yu L. Molecular cloning and functional expression of a μ-opioid receptor from rat brain. Mol. Pharmacol. 44:1993;8-12.
10. Chieng B., Christie M.J. Inhibition by opioids acting on μ-receptors of GABAergic and glutamatergic postsynaptic potentials in single rat periaqueductal gray neurones in vitro. Br. J. Pharmacol. 113:1994;303-309.
11. Chieng B., Keay K.A., Christie M.J. Increased fos-like immunoreactivity in the periaqueductal gray of anaesthetised rats during opiate withdrawal. Neurosci. Lett. 183:1995;79-82.
12. Childers S.R. Opioid receptor-coupled second messenger systems. Life Sci. 48:1991;1991-2003.
13. Clements J.R., Madl J.E., Johnson R.L., Larson A.A., Beitz A.J. Localization of glutamate, glutaminase, aspartate and aspartate aminotransferase in the rat midbrain periaqueductal gray. Exp. Brain Res. 67:1987;594-602.
14. Couceyro P., Douglass J. Precipitated morphine withdrawal stimulates multiple activator protein-1 signalling pathways in rat brain. Mol. Pharmacol. 47:1995;29-39.
15. 5]enkephalin levels. Eur. J. Pharmacol. 203:1991;93-103.
16. Curran T., Franza B.R., Fos J., Jun The AP-1 connection. Cell. 55:1988;395-397.
17. Delfs J.M., Kong H., Mestek A., Chen Y., Yu L., Reisine T., Chesselet M.-F. Expression of μ-opioid receptor mRNA in rat brain: an in situ hybridization study at the single cell level. J. Comp. Neurol. 345:1994;46-68.
18. Duman R.S., Tallman J.F., Nestler E.J. Acute and chronic opiate-regulation of adenylate cyclase in brain: specific effects in locus coeruleus. J. Pharmacol. Exp. Ther. 246:1988;1033-1039.
19. Elsworth J.D., Redmond D.E. Jr., Roth R.H. Effect of morphine treatment and withdrawal on endogenous methionine- and leuicine-enkephalin levels in primate brain. Biochem. Pharmacol. 35:1986;3415-3417.
20. Fedynyshyn J.P., Lee N.M. μ-type opioid receptors in rat periaqueductal gray-enriched P2 membrane are coupled to guanine nucleotide binding proteins. Brain Res. 476:1989;102-109.
21. Folkesson R., Monstein H.-J., Geijer T., Terenius L. Modulation of proenkephalin A gene expression by cyclic AMP. Mol. Brain Res. 5:1989;211-217.
22. Fratta W., Yang H.-Y.T., Hong J., Costa E. Stability of Met-enkephalin content in brain structures of morphine-dependent or foot shock-stressed rats. Nature. 268:1977;452.
23. Fukunaga Y., Nishida S., Inoue N., Kishioka S., Yamamoto H. Increase of preproenkephalin mRNA in the caudal part of periaqueductal gray by morphine withdrawal in rats: a quantitative in situ hybridization study. Mol. Brain Res. 42:1996;128-130.
24. George S.R., Zastawny R.L., Briones-Urbine R., Cheng R., Nguyen T., Heiber M., Kouvelas A., Chan A.S., O'Dowd B.F. Distinct distributions of μ-, δ- and κ-opioid receptor mRNA in rat brain. Biochem. Biophys. Res. Commun. 205:1994;1438-1444.
25. Gioia M., Bianchi R. The distribution of substance P and Met-enkephalin in the periaqueductal gray matter of the rat. Basic Appl. Histochem. 32:1988;103-108.
26. Gudehithlu K.P., Bhargava H.N. Modulation of preproenkephalin mRNA levels in brain regions and spinal cord of rats treated chronically with morphine. Peptides. 16:1995;415-419.
27. Gudehithlu K.P., Tejwani G.A., Bhargava H.N. β-endorphin and methionine-enkephalin levels in discrete brain regions, spinal cord, pituitary gland and plasma of morphine tolerant-dependent and abstinent rats. Brain Res. 533:1991;284-290.
28. Haffmans J., Dzoljic M.R. Inhibition of enkephalinase activity attenuates naloxone-precipitated withdrawal symptoms. Gen. Pharmacol. 18:1987;103-105.
29. Harbuz M., Russell J.A., Sumner B.E.H., Kawata M., Lightman S.L. Rapid changes in the content of proenkephalin A and corticotrophin releasing hormone mRNAs in the paraventricular nucleus during morphine withdrawal in urethane-anaesthetized rats. Mol. Brain Res. 9:1991;285-291.
30. Herz A. Role of endorphins in addiction. Mob. Probl. Pharmacopsychiat. 17:1981;175-180.
31. Hoffman K.E., Maslonek K.A., Dykstra L.A., Lysle D.T. Effects of central administration of morphine on immune status in Lewis and Wistar rats. Adv. Exp. Med. Biol. 373:1995;155-159.
32. Hollt V., Haarmann I., Reimer S. Opioid peptide gene expression in rats after chronic morphine treatment. Adv. Biosci. 75:1989;711-714.
33. Ichitani Y., Iwasaki T. Approach and escape responses to mesencephalic central gray stimulation in rats: effects of morphine and naloxone. Behav. Brain Res. 22:1986;63-73.
34. Iglesias T., Montero S., Otero M.J., Parra L., Fuentes J.A. Preproenkephalin RNA increases in the hypothalamus of rats stressed by social deprivation. Cell. Mol. Neurobiol. 12:1992;547-555.
35. Koob G.F., Maldonado R., Stinus L. Neural substrates of opiate withdrawal. TINS. 15:1992;186-191.
36. Koyuncuoglu H., Dizdar Y., Aricioglu F., Sayin U. Effects of MK 801 on morphine physical dependence: attenuation and intensification. Pharmacol. Biochem. Behav. 43:1992;487-490.
37. Larsen P.J., Mau S.E. Effect of acute stress on the expression of hypothalamic messenger ribonucleic acids encoding the endogenous opioid precursors preproenkephalin A and proopiomelanocortin. Peptides. 15:1994;783-790.
38. Laschka E., Teschemacher H., Mehraein P., Herz A. Sites of action of morphine involved in the development of physical dependence in rats: II. Morphine withdrawal precipitated by application of morphine antagonists into restricted parts of the ventricular system and by microinjection into various brain areas. Psychopharmacologia. 46:1976;141-147.
39. Lightman S.L., Young III W.S. Changes in hypothalamic preproenkephalin A mRNA following stress and opiate withdrawal. Nature. 328:1987;643-645.
40. Maldonado R., Fournie-Zaluski M.C., Roques B.P. Attenuation of the morphine withdrawal syndrome by inhibition of catabolism of endogenous enkephalins in the periaqueductal gray matter. Naunyn-Schmiedeberg's Arch. Pharmacol. 345:1992;466-472.
41. Maldonado R., Stinus L., Gold L.H., Koob G.F. Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J. Pharmacol. Exp. Ther. 261:1992;669-677.
42. Malick J.B., Goldstein J.M. Analgesic activity of enkephalins following intracerebral administration in the rat. Life Sci. 20:1977;827-832.
43. Mansour A., Fox C.A., Akil H., Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. TINS. 18:1995;22-29.
44. Nestler E.J., Tallman J.F. Chronic morphine treatment increases cyclic AMP-dependent protein kinase activity in the rat locus coeruleus. Mol. Pharmacol. 33:1988;127-132.
45. Parolaro D., Crema G., Sala M., Santagostino A., Giagnoni G., Gori E. Intestinal effect and analgesia: evidence for different involvement of opioid receptor subtypes in periaqueductal gray matter. Eur. J. Pharmacol. 120:1986;95-99.
46. G. Paxinos, C. Watson, The rat brain in sterotaxic coordinates, Academic Press, San Diego, 1982.
47. Pierce T.L., Tiong G.K.L., Olley J.E. Morphine and methadone dependence in the rat: Withdrawal and brain Met-enkephalin levels. Pharmacol. Biochem. Behav. 42:1992;91-96.
48. Rasmussen K., Beitner-Johnson D.B., Krystal J.H., Aghajanian G.K., Nestler E.J. Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates. J. Neurosci. 10:1990;2308-2317.
49. Rasmussen K., Fuller R.W., Stockton M.E., Perry K.W., Swinford R.M. NMDA receptor antagonists suppress behaviors but not norepinephrine turnover or locus coeruleus unit activity induced by opiate withdrawal. Eur. J. Pharmacol. 197:1991;9-16.
50. Robertson J.A., Bodner R.J. Site-specific modulation of morphine and swim-induced antinociception following thyrotropin-releasing hormone in the rat periaqueductal gray. Pain. 55:1993;71-84.
51. Rossi G., Pan Y.-X., Cheng J., Pasternak G.W. Blockade of morphine analgesia by an antisense oligodeoxynucleotide against the μ-receptor. Life Sci. 54:1994;PL375-379.
52. Ruda M.A. An autoradiographic study of the efferent connections of the midbrain central gray in the cat. Anat. Rec. 181:1975;468-469.
53. Sala M., Parolaro D., Crema G., Spazzi L., Giagnoni G., Cesana R., Gori E. Involvement of periaqueductal gray matter in intestinal effect of centrally administered morphine. Eur. J. Pharmacol. 91:1983;251-254.
54. Sharma S.K., Klee W.A., Nirenberg M. Dual regulation of adenylate cyclase accounts for narcotic dependence and tolerance. Proc. Natl. Acad. Sci. U.S.A. 72:1975;3092-3096.
55. Sonnenberg J.L., Rauscher F.J. III, Morgan J.I., Curran T. Regulation of proenkephalin by Fos and Jun. Science. 246:1989;1622-1625.
56. Stornetta R.L., Norton F.E., Guyenet P.G. Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats. Brain Res. 624:1993;19-28.
57. Terwilliger R.Z., Beitner-Johnson D., Sevarino K.A., Crain S.M., Nestler E.J. A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function. Brain Res. 548:1991;100-110.
58. Uhl G.R., Ryan J.P., Schwartz J.P. Morphine alters preproenkephalin gene expression. Brain Res. 459:1988;391-397.
59. Waksman G., Hamel E., Fourine-Zaluski M.-C., Roques B.P. Autoradiographic comparison of the distribution of the neutral endopeptidase enkephalinase and of μ- and δ-opioid receptors in rat brain. Proc. Natl. Acad. Sci. U.S.A. 83:1986;1523-1527.
60. Wang Q.-P., Guan J.-L., Nakai Y. Immunoelectron microscopy of enkephalinergic innervation of GABAergic neurons in the periaqueductal gray. Brain Res. 665:1994;39-46.
61. Weber R.J., Pert A. The periaqueductal gray matter mediates opiate-induced immunosuppression. Science. 245:1989;188-190.
62. Wei E.T. Enkephalin analogs and physical dependence. J. Pharmacol. Exp. Ther. 216:1981;12-18.
63. Williams F.G., Mullet M.A., Beitz A.J. Basal release of Met-enkephalin and neurotensin in the ventrolateral periaqueductal gray matter of the rat: a microdialysis study of antinociceptive circuits. Brain Res. 690:1995;207-216.
64. Yaksh T.L., Yeung J.C., Rudy T.A. Systematic examination in the rat of brain sites sensitive to the direct application of morphine: observation of differential effects within the periaqueductal gray. Brain Res. 114:1976;83-103.
65. Yeung J.C., Yaksh T.L., Rudy T.A. Concurrent mapping of brain sites for sensitivity to the direct application of morphine and focal electrical stimulation in the production of antinociception in the rat. Pain. 4:1977;23-40.
66. Yosikawa K., Williams C., Sabol S.L. Rat brain preproenkephalin mRNA. J. Biol. Chem. 259:1984;14301-14308.
67. Young W.S. III, Lightman S.L. Chronic stress elevates enkephalin expression in the rat paraventricular and supraopticnuclei. Mol. Brain Res. 13:1992;111-117.
68. Zenker N., Bernstein D.E. The estimation of small amounts of corticosterone in rat plasma. J. Biol. Chem. 231:1958;695-701.